SANTA CRUZ, Calif., Mar 18, 2008 (BUSINESS WIRE) — CAII | news | PowerRating | PR Charts — The 10th Anniversary C21 BioVentures (C21) conference has announced new details for what will be an exciting and informative program for 2008. C21, produced by Technology Vision Group LLC and co-hosted by BayBio and the National Venture Capital Association, will be held from May 20-22, 2008 at the Meritage Resort in Napa, California. This year C21 returns to the beautiful Napa Valley, home to internationally known wineries, 4-star restaurants, and world class golf. Providing a relaxed environment to do business, C21 seeks to provide as many networking, partnering, and financing opportunities as possible during a packed 3-day program, which this year includes a golf tournament and bioentrepreneur roundtable, in addition to the BioVenture Leadership and Trends and Issues sessions that take place at C21 every year. Topical and Informative Sessions Featuring Industry Leaders

The C21 program annually addresses cutting edge themes of interest to the lifescience and venture capital communities. Among the most popular features of the C21 program are the Trends & Issues Sessions. These sessions will be led by many of the leading thinkers and entrepreneurs in the industry including executives from Comerica, Cooley Godward Kronish LLP, Deloitte, Ferghana Partners Group, Novartis, Procter & Gamble, Oppenheimer, Prism Venture Partners, Scale Venture Partners, and TVM Capital. Program details can be found online at http://www.techvision.com/c21/program/.

This year’s program will also feature a BioEntrepreneur Roundtable with Nature Publishing Group on Tuesday, May 20th. Entitled “BioEntrepreneur Beware: CEO War Stories on Investor Nightmares” the discussion will explore what could go wrong during the financing process. More informal networking will also be available during the inaugural BayBio Institute Classic golf tournament, benefiting the non-profit BayBio Institute, which will also be held on Tuesday, May 20th. Details and registration information for the golf tournament can be found at http://www.baybio.org/institute/wt/page/golf_1st_tourney.

Register Now - Early Bird Rate is still available!

Registration for C21 includes pre-arranged one-to-one partnering meetings, access to biopartnering.com, admittance to all presentations and sessions, breakfasts, lunches, refreshment breaks and 3 receptions, as well as the conference handbook & CD.

Register by April 18th and take advantage of the early rate at: www.techvision.com/c21/registration.

Institutional investors may also benefit from a reduced rate, please visit the website for further details.

biopartnering.com

A unique and powerful internet tool, biopartnering.com allows the proactive delegate to prepare for C21 prior to arriving. Presenters are able to access the password protected area of the site to research investment opportunities through keyword searches of detailed profiles on all companies, contact other delegates, and stay informed of additions to the program. biopartnering.com is now open and available for C21 paid attendees, and onsite meeting scheduling will begin April 22nd, so register now and begin planning for C21 BioVentures!

Confirmed Presenting Companies:

4-Antibody AG, Accera, Inc., Adlyfe Inc, AltheaDx, Alvine Pharmaceuticals, AmpliMed Corporation, Anaptys Biosciences, Inc., Antigen Discovery Incorporated, ApopLogic Pharmaceuticals, LLC, Asphelia Pharmaceuticals, Astute Medical, Inc., Attagene, Axela Inc., Azaya Therapeutics, Inc., BaroFold, Inc., BayPoint Biosystems, Bennett Biotech, Biothera, Calibrant Bio, Celator Pharmaceuticals, Cequent Pharmaceuticals, CG Pharmaceuticals, Chimeracore, Inc., Codon Devices, Colby Pharmaceutical Company, CoMentis, Inc., Coronado Biosciences, Evolva SA, Farallone Therapeutics, Genyous Biomed, GlobeImmune, Inc., Immune Control, Intradigm Corporation, KAI Pharmaceuticals, Inc., Kereos, Inc., Kiadis pharma B.V., Kinagen Inc., Lentigen Corporation, Light Sciences Oncology, Magen BioSciences, Maven Biotechnologies LLC, Melior Discovery, Inc., Nanospectra Biosciences, Inc., Neosil, Nerites, Network Biosystems, Inc, OsteoCorp Inc., PlexPress, PLx Pharma Inc., Regenesis Biomedical, Ribomed Biotechnologies, Inc, Semafore Pharmaceuticals, Inc., Sidec, Silamed, Inc., The Vaccines Company, TheraVida, Trellis Bioscience, Vaxart, VentiRx Pharmaceuticals, VM Discovery, Xceed Molecular, Zymeworks Inc.

– via TradingMarkets

Tags: Vaxart